Drugs / Indian Costus
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04553705 | Sep → Nov 2020 | COVID-19, immunodeficiency disease | Beni-Suef University | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT05623605 | Jun → Dec 2022 | dental caries | Nahda University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Indian costus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05623605 ↗ |